Medical News

RSS

Israeli OCS approves $1.7M grant to support PROLOR's hGH-CTP program

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the Israeli Office of the Chief Scientist (OCS) has approved a 2011 grant to PROLOR's Israeli-based R&D subsidiary for the company's development program for hGH-CTP, its long-acting version of human growth hormone.

10 Aug 2011

Accretive Health second quarter net income increases 118% to $8.6 million

Accretive Health, Inc., a leading provider of comprehensive end-to-end healthcare revenue cycle management services and population health management services infrastructure, today announced financial results for the quarter ended June 30, 2011.

10 Aug 2011

Cancer-causing fusion protein works by silencing tumor suppressor gene IL-2Rγ

Mariusz A. Wasik, MD, professor of Pathology and Laboratory Medicine, and Qian Zhang, MD, PhD, research assistant professor, both from the Perelman School of Medicine at the University of Pennsylvania, and their colleagues, found that a cancer-causing fusion protein works by silencing the tumor suppressor gene IL-2R common gamma-chain.

10 Aug 2011

Winner Medical third quarter net sales increase 34% to $41.5 million

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the third quarter ended June 30, 2011.

10 Aug 2011

YASOO Health launches grape flavored liquid iron supplement for children

YASOO Health Inc, Morrisville, NC has introduced IronUp, a Liquid Iron Supplement specifically formulated to supplement the levels of dietary iron for infants and children who do not receive adequate amounts in their diets.

10 Aug 2011

Protox reports net loss of $3.2 million for second quarter 2011

Protox Therapeutics Inc., a developer of innovative products for the treatment of urological diseases, today announced financial results and achievements for the quarter ended June 30, 2011.

10 Aug 2011

Study: Expanded insurance coverage alone may not mean better access to care

A shortage in the number and availability of primary care physicians may continue to mean rising numbers of emergency department visits, despite the expanded health insurance coverage required by the 2010 Patient Protection and Affordable Care Act.

10 Aug 2011

Study suggests ways to remediate cognitive errors

Concern about the capacity of individuals with schizophrenia to consent to clinical research studies has largely focused on impairment due to psychotic symptoms associated with the disorder. Less attention has been given to the cognitive errors that prospective participants make when undergoing a formal assessment of decisional capacity.

10 Aug 2011

TrovaGene regains ownership of worldwide rights to transrenal technology

TrovaGene, Inc., a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc.

10 Aug 2011

New policy research examines financial impact of North Carolina's community health centers

A new policy research brief released today by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at The George Washington University School of Public Health and Health Services examines the financial impact of community health centers in North Carolina, a state known for its primary care innovation.

10 Aug 2011

Glenmark commences Revamilast Phase IIb trial in chronic inflammatory disorders

Glenmark Pharmaceuticals today announced that its Novel Chemical Entity "Revamilast" (GRC 4039) has initiated Phase IIb human dose range finding trials globally. Revamilast is an orally active, potent and selective inhibitor of phosphodiesterase 4 (PDE 4) that is currently being developed by Glenmark for the treatment of chronic inflammatory disorders such as Asthma, Rheumatoid Arthritis (RA) and other inflammatory diseases.

10 Aug 2011

Acorda Therapeutics receives U.S. patent allowance for aminopyridine compositions

Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/102,559 entitled "Method of Using Sustained Release Aminopyridine Compositions."

10 Aug 2011

Nesfatin-1 protein may help reduce body weight and blood sugar

A newly-identified protein may hold the key to keeping appetite and blood sugar in check, according to a study by York University researchers.

10 Aug 2011

U.S. can do more to reverse famine in Horn of Africa

Former Senate Majority Leader Bill Frist, who is traveling in East Africa with a U.S. delegation "to study the famine affecting the lives of over 12 million people, many of them children," writes in the Huffington Post's blog, "Huffpost Impact," that the group will assess "what more we as a nation can do."

10 Aug 2011

Study examines role of weight lifting in smoking cessation

Resistance training, or weight lifting, can do more than just build muscle: it may also help smokers kick the habit, say researchers from The Miriam Hospital's Centers for Behavioral and Preventive Medicine.

10 Aug 2011

Global endoscopy equipment market to reach $33.7 billion by 2016: New report

By 2016 it is believed that the global endoscopy equipment market will be worth in excess of $33.7 billion, growing at a CAGR of 6.4% over the reporting period, according to a new report available on companiesandmarkets.com.

10 Aug 2011

Food fortification aims to improve nutrition in Egypt

The Bill & Melinda Gates Foundation features a video from the Living Proof Project highlighting a Global Alliance for Improved Nutrition (GAIN) program in Egypt that is "reducing malnutrition through food fortification strategies aimed at improving the health and nutrition of populations at risk."

10 Aug 2011

ABTC receives NCCA accreditation for three transplant certification examinations

Three certification examinations of the American Board for Transplant Certification (ABTC) are now accredited by the National Commission for Certifying Agencies.

10 Aug 2011

Study finds demand continues for safety-net care in Massachusetts

Even though the state reduced the number of uninsured residents in its health care overhaul, many people still get treatments at community health centers and safety-net hospitals.

10 Aug 2011

Scientist determines how nyctalopin gene makes night vision possible

A scientist from the Florida campus of The Scripps Research Institute has determined how a particular gene makes night vision possible. The study, which was published in the August 10, 2011 edition of The Journal of Neuroscience, focuses on a gene called nyctalopin. Mutations in the gene result in inherited "night blindness," a loss of vision in low-light environments.

10 Aug 2011